Bempedoic acid
Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].
Product Specifications
CAS Number
[738606-46-7]
Product Name Alternative
ETC-1002; ESP-55016
UNSPSC
12352211
Hazard Statement
H302, H312, H332
Target
AMPK; ATP Citrate Lyase
Type
Reference compound
Related Pathways
Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ETC-1002.html
Concentration
10mM
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
Molecular Formula
C19H36O5
Molecular Weight
344.49
Precautions
H302, H312, H332
References & Citations
[1]Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54 (1) :134-51.|[2]Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54 (8) :2095-108.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
AMPK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
A2296-71 200 µL
ANO5, CT (Anoctamin-5, Transmembrane protein 16E, Gnathodiaphyseal dysplasia 1 protein, TMEM16E, GDD1, ANO5)
Ask
View Details